A patient’s mental preparedness counts
Often, a cancer diagnosis imparts a sense of urgency — a desire on the part of the patient to begin treatment as soon as possible, to vanquish their disease and resume a normal life.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
But what does a physician do when a patient isn’t ready?
In his latest New York Times column, Cleveland Clinic hematologist/oncologist Mikkael Sekeres, MD, MS, recounts how he responded to a patient who was hesitant about starting chemotherapy
Read the full column here.
Dr. Sekeres, Director of Cleveland Clinic Cancer Center’s Leukemia Program and Vice-chair for Clinical Research, writes regularly for the Times and other publications about his experiences as an oncologist. You can follow him on Twitter @MikkaelSekeres.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients